EUCTR2020-005633-33-NL进行中（未招募）1 期
Prediction of ECT treatment response and reduction of Cognitive Side-effects using EEG and Rivastigmine
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age over 18 years
- •-Clinical indication for ECT (as indicated by the treating physician/psychiatrist)
- •-Uni- or bipolar depression (as assessed by the treating psychiatrist)
- •-Dutch as first language
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •- Currently receiving, or having received ECT 6 months prior to the start of the treatment/study.
- •- Currently using rivastigmine, galantamine, donezepil (all cholinesterase inhibitors for mild to moderate Alzheimer’s Disease).
- •- Pregnancy and/or lactation/breast feeding
- •- Suspicion of neurodegenerative disorders (as diagnosed earlier)
- •- Contraindications for ECT (recent myocardinfarct, recent cerebrovasculair accident, recent intracranial surgery, pheochromocytoma and instable angina pectoris)
- •- Contraindications for rivastigmine (bradycardia or atrioventricular (AV) conduction disorders (first degree AV-block excluded))
- •- Patients who have had an allergic reaction to rivastigmine
- •- Cognitive disorder not explained by the depressive episode
研究者
相似试验
招募中
不适用
Prediction of ECT treatment response and reduction of Cognitive Side-effects using EEG and RivastigmineDepressionNL-OMON27806MC Groningen (investigator initiated)100
招募中
不适用
Prediction of ECT treatment response and reduction of Cognitive Side-effects using EEG and RivastigmineDepressionNL-OMON54344niversitair Medisch Centrum Groningen100
招募中
不适用
Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosisDRKS00010936Klinik und Poliklinik für Psychiatrie und Psychotherapie,LVR-Klinikum Düsseldorf / Kliniken der Heinrich Heine Universität Düsseldorf600
已完成
不适用
The effect of electroconvulsive therapy (ECT) following propofol and etomidate anaesthesia: a randomised double blind trial.Mental and Behavioural Disorders: Electroconvulsive therapy (ECT)Mental and Behavioural DisordersElectroconvulsive therapy (ECT)ISRCTN86210347Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
招募中
不适用
Optimization of electroconvulsive therapy (ECT) and continuation pharmacotherapy in major depressive disorderdepressionMajor depression10027946NL-OMON33909Erasmus MC, Universitair Medisch Centrum Rotterdam90